Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Penumbra, Inc.

Market Cap 12.44B 10.73B 9.86B 9.28B 17.44B 1,174B 17.59B 117B 45.5B 576B 46.67B 45.67B 1,992B P/E 2026 *
62.6x
P/E 2027 * 50x
Enterprise Value 11.91B 10.28B 9.45B 8.89B 16.71B 1,124B 16.85B 112B 43.59B 552B 44.71B 43.75B 1,909B EV / Sales 2026 *
7.45x
EV / Sales 2027 * 6.51x
Free-Float
97.1%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week-1.00%
Current month-0.67%
1 month-1.91%
3 months-6.46%
6 months+2.23%
Current year+1.69%
1 week 315.98
Extreme 315.985
321.8
1 month 315.98
Extreme 315.985
329.67
Current year 290
Extreme 290
362.41
1 year 221.26
Extreme 221.26
362.41
3 years 148
Extreme 148
362.41
5 years 114.86
Extreme 114.865
362.41
10 years 54.96
Extreme 54.96
362.41
Manager TitleAgeSince
Chief Executive Officer 64 20/06/2004
President 42 31/08/2025
Director of Finance/CFO 54 01/12/2019
Director TitleAgeSince
Director/Board Member 62 12/01/2017
Director/Board Member 59 31/03/2015
Chairman 64 31/12/2014
Date Insider Type Main position Quantity % Market Cap.
05-18Don

Chief Executive Officer

-77,000 0.1958%
04-01Sell

Director

100 0.0003%
03-14Tax

Chairperson

117 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%-1.00%+23.52%-6.29% 12.44B
-0.06%-5.55%+59.65%+28.95% 5.98B
-0.79%+1.68%+5.19%-23.42% 5.61B
-3.61%-3.67% - - 3.98B
+0.26%+1.02%-29.86%+16.32% 4.1B
-0.86%-0.83%-28.80%-25.13% 3.73B
+2.06%+7.21%+2.41%-59.62% 2.07B
-0.66%+6.18%+46.94%+217.99% 1.81B
-1.20%-3.60%+55.69%-7.22% 1.55B
-0.23%-3.56%-17.62%-53.69% 1.26B
Average -0.56%-0.50%+13.01%+9.77% 4.25B
Weighted average by Cap. -0.68%-0.96%+15.64%+3.36%

Financials

2026 *2027 *
Net sales 1.6B 1.38B 1.27B 1.19B 2.24B 151B 2.26B 15.03B 5.85B 74.04B 6B 5.87B 256B 1.8B 1.55B 1.43B 1.34B 2.53B 170B 2.55B 16.92B 6.59B 83.38B 6.76B 6.61B 288B
Net income 196M 169M 155M 146M 274M 18.45B 277M 1.84B 716M 9.06B 734M 718M 31.33B 250M 215M 198M 186M 350M 23.56B 353M 2.35B 913M 11.56B 937M 917M 40B
Net Debt -523M -451M -414M -390M -733M -49.31B -739M -4.91B -1.91B -24.2B -1.96B -1.92B -83.72B -718M -620M -570M -536M -1.01B -67.79B -1.02B -6.75B -2.63B -33.27B -2.7B -2.64B -115B
Logo Penumbra, Inc.
Penumbra, Inc. is a thrombectomy company, which is focused on developing technologies for challenging medical conditions, such as ischemic stroke, venous thromboembolism, such as pulmonary embolism, and acute limb ischemia. The Company's broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe. It focuses on developing, manufacturing and marketing novel products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. Some of the conditions it focuses on are Pulmonary Embolism, Deep Vein Thrombosis, Acute Limb Ischemia, Ischemic Stroke, Acute Coronary Syndrome, and Clot associated with Arteriovenous Graft or Fistula. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada, Australia and Singapore, as well as through distributors in select international markets.
Employees
4,700
Date Price Change Volume
17/06/26 316.16 $ -0.72% 384,665
16/06/26 318.46 $ +0.08% 279,260
15/06/26 318.21 $ -0.16% 446,357
12/06/26 318.71 $ +0.12% 514,479
11/06/26 318.32 $ -0.32% 335,802
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
316.16USD
Average target price
363.36USD
Spread / Average Target
+14.93%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!